FDA
-
-
-
-
-
-
-
Argos Therapeutics (ARGS) Announces Update on Immunology Data from the Phase 3 ADAPT Trial
-
-
-
-
-
-
-
Argos Therapeutics (ARGS) Announces $6M Secured Convertible Note Financing
-
-
-
-
-
-
-
Needham & Company Downgrades Argos Therapeutics (ARGS) to Hold
-
-
-
322,938 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

